September 10, 2007
Eli Lilly, Takeda Terminate Agreement on Ruboxistaurin Eli Lilly Japan and Takeda Pharmaceutical jointly announced on August 30 that the agreement signed by Eli Lilly and Company, the parent company of Eli Lilly Japan, and Takeda to jointly develop and...read more